DURECT
  • ABOUT
    • ABOUT DURECT
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • CORPORATE GOVERNANCE
      • BOARD COMMITTEE CHARTERS
      • CODE OF ETHICS
      • WHISTLEBLOWER POLICY
      • CORPORATE GOVERNANCE GUIDELINES
  • MEDICINES
    • POSIMIR® (bupivacaine solution)
  • PIPELINE
    • OVERVIEW
    • DUR-928
      • ABOUT DUR-928
      • EPIGENETIC REGULATION
      • ALCOHOLIC-ASSOCIATED HEPATITIS
      • NONALCOHOLIC STEATOHEPATITIS (NASH)
      • PUBLICATIONS
      • EXPANDED ACCESS POLICY
  • CLINICAL TRIALS
    • AHFIRM
  • TECHNOLOGIES
    • LONG-ACTING INJECTABLES
      • SABER® PLATFORM
      • CLOUD™ PLATFORM
    • ORADUR™ ABUSE-DETERRENT TECHNOLOGY
    • ALZET® Osmotic Pumps
  • INVESTORS
    • OVERVIEW
    • FACTSHEETS
    • STOCK INFORMATION
    • NEWS RELEASES
    • COLLABORATIONS
    • EARNINGS ESTIMATE
    • ANALYST COVERAGE
    • CORPORATE PRESENTATION
    • SEC FILINGS
    • EVENT CALENDAR
    • FAQs
    • EMAIL ALERTS
    • INFORMATION REQUEST
  • NEWS
    • NEWS RELEASES
    • MEDIA KIT

ABOUT

  • ABOUT DURECT
  • MANAGEMENT
  • BOARD OF DIRECTORS
  • CORPORATE GOVERNANCE
    • BOARD COMMITTEE CHARTERS
    • CODE OF ETHICS
    • WHISTLEBLOWER POLICY
    • CORPORATE GOVERNANCE GUIDELINES

Board Committee Charters

Charter for the Audit Committee of the Board of Directors (PDF)

Charter for the Compensation Committee of the Board of Directors (PDF)

Nominating and Corporate Governance Committee Charter (PDF)

© 2000-2021 DURECT Corporation

Twitter       LinkedIn

BUSINESS DEVELOPMENT | CAREERS | CONTACT | LEGAL NOTICE | PRIVACY POLICY

ALZET logo

DURECT manufactures ALZET® osmotic pumps.